Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neuro20 Pro System

K-Number: K223797 · 2023-02-23

Decision Date2023-02-23
Product CodeNGX
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

Neuro20 Pro System is the device name listed in this FDA 510(k) record. The listed applicant is Neuro20 Technologies. It received FDA 510(k) clearance on 2023-02-23 under 510(k) number K223797. The device is classified under product code NGX. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neuro20 Pro System?

Neuro20 Pro System is a medical device that received FDA 510(k) clearance on 2023-02-23. The listed applicant is Neuro20 Technologies. The 510(k) number is K223797.

When did Neuro20 Pro System receive FDA 510(k) clearance?

Neuro20 Pro System received FDA 510(k) clearance on 2023-02-23, under 510(k) number K223797.

Who is the listed applicant for Neuro20 Pro System?

The FDA 510(k) record lists Neuro20 Technologies as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Neuro20 Pro System?

The FDA product code for Neuro20 Pro System is NGX.

Related Devices (Code: NGX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.